The Gross Margin of InDex Pharmaceuticals Holding AB (INDEX.ST) is -81.95%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | -81.95% |
| 2022-12-31 | -134217.14% |
| 2021-12-31 | -4335.23% |
| 2020-12-31 | -337.50% |
| 2019-12-31 | -7862.83% |
| 2018-12-31 | -3480.11% |
| 2017-12-31 | -278.19% |
| 2016-12-31 | 88.94% |